Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

AI-powered evaluation of dementia severity based on clinical data and visual scoring systems (MTA, ERICA, GCA) from MRI.

Scientific reports·2026
Same author

Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study.

BMC health services research·2026
Same author

Web-Based Application for Cognitive and Functional Assessments in Dementia Screening: Mixed Methods, User-Centered Development Approach.

JMIR human factors·2026
Same author

Psychometric validation and cross-cultural adaptation of the dementia knowledge assessment Scale-Thai (DKAS-Thai).

BMC geriatrics·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Vorapun Senanarong1,2, Tanyaluck Thientunyakit3, Chatchawan Rattanabannakit2

  • 1Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj hospital, Mahidol university, Bangkok, Thailand.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

这项研究确定了在泰国诊断阿尔茨海默病 (AD) 的血生物标志物的最佳切断值. 血p-tau217在区分AD与非AD群体方面表现出最高的准确性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 痴呆症的诊断 痴呆症的诊断

背景情况:

  • 阿尔茨海默病 (AD) 诊断依赖于侵入性方法.
  • 基于等离子体的生物标志物为AD检测提供了一个不那么侵入性的替代方案.
  • 确定局部截止值对于特定人口的准确性至关重要.

研究的目的:

  • 确定阿尔茨海默病 (AD) 血生物标志物的局部切断值.
  • 评估血生物标志物的诊断性能,以区分泰国人口中的AD和非AD亚组.
  • 为了验证血生物标记物与粉样蛋白PET和CSF标记物相比.

主要方法:

  • 涉及97名参与者的前性研究 (AD,非AD痴呆症,MCI/对照).
  • 分析了Aβ-PET (18F-florbetapir) 和等离子体生物标志物 (Aβ40,Aβ42,p-tau181,pTau217,GFAP) 的情况.
  • 使用接收器操作特征 (ROC) 分析来确定切断值.

主要成果:

  • 血p-tau217在区分AD阳性和AD阴性组中显示了最高的准确性 (87.14%).
  • 血GFAP (77.89%),pTau181 (73.20%) 和Aβ42/40比率 (72.63%) 也显示出显著的诊断性能.
  • 所有测试的血生物标志物都显示出有前途的诊断能力.

结论:

  • 血生物标志物在痴呆症诊断中具有显著的临床使用潜力.
  • 血p-tau217是区分AD最有效的生物标志物.
  • 这些发现支持使用血生物标志物在泰国人口中诊断AD.